• ProMIS Neurosciences Inc. is trading at $11.42 (13.6% up) in after-hours, rebounding from recent declines.
  • The company's CEO is presenting at the H.C. Wainwright Neuro Perspectives Expert Summit today, June 15, 2026, to discuss its EpiSelect™ platform and Alzheimer's candidate PMN310.
  • This follows a Zacks Rank #2 (Buy) upgrade for PMN on June 12, 2026, driven by an upward trend in earnings estimates.